Phase 1 Dose-Escalation Study of [ <sup>225</sup> Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry

Authors

Livia Chilug (ORCID: https://orcid.org/0000-0001-6553-8213)
Tessa Brabander (ORCID: https://orcid.org/0000-0002-8000-6490)
Sui Wai Ling (ORCID: https://orcid.org/0000-0003-1084-631X)
Marcel Segbers (ORCID: https://orcid.org/0000-0002-4866-3984)
Eline Hooijman
Astrid van der Veldt
Frank Bruchertseifer
Alfred Morgenstern
Mark Konijnenberg
Andrea van Puffelen
Erik de Blois
Stijn Koolen
Linda C. De Jong
Quido de Lussanet de la Sabloniere

Institutions

Erasmus MC (NL)
Joint Research Centre (DE)
Erasmus MC Cancer Institute (NL)
Erasmus University Rotterdam (NL)

Publication Details

Journal: Journal of Nuclear Medicine
Published: 2026-04-22
DOI: https://doi.org/10.2967/jnumed.125.271880
Primary Topic: Prostate Cancer Treatment and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Phase 1 Dose-Escalation Study of [ ²²⁵ Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry

Livia Chilug, Tessa Brabander, Sui Wai Ling, Marcel Segbers et al.

Apr 22, 2026

Journal of Nuclear Medicine

Prostate Cancer Treatment and Research

article

Phase 1 Dose-Escalation Study of [ ²²⁵ Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry

Livia Chilug, Tessa Brabander, Sui Wai Ling, Marcel Segbers, Eline Hooijman, Astrid van der Veldt, Frank Bruchertseifer, Alfred Morgenstern, Mark Konijnenberg, Andrea van Puffelen, Erik de Blois, Stijn Koolen, Linda C. De Jong, Quido de Lussanet de la Sabloniere

April 22, 2026article en

Abstract

No abstract available for this paper.

Journal of Nuclear Medicine

Erasmus MC (NL), Joint Research Centre (DE), Erasmus MC Cancer Institute (NL), Erasmus University Rotterdam (NL)

Good health and well-being

Openalex Percentile: Top 16%

Prostate Cancer Treatment and Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.